QIAGEN N.V. Files Q1 2024 6-K Report
Ticker: QGEN · Form: 6-K · Filed: May 1, 2024 · CIK: 1015820
| Field | Detail |
|---|---|
| Company | Qiagen N.V. (QGEN) |
| Form Type | 6-K |
| Filed Date | May 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: quarterly-report, foreign-private-issuer
Related Tickers: QGEN
TL;DR
QIAGEN dropped its Q1 2024 6-K, check it for performance updates.
AI Summary
QIAGEN N.V. filed a Form 6-K for the quarterly period ended March 31, 2024. The filing is a report of a foreign private issuer and includes information on other matters, signatures, and an exhibit index. The company's principal executive office is located in Venlo, The Netherlands.
Why It Matters
This filing provides an update on QIAGEN's financial reporting for the first quarter of 2024, which is crucial for investors to assess the company's performance and make informed decisions.
Risk Assessment
Risk Level: low — This filing is a routine quarterly report and does not contain significant new risks or material adverse events.
Key Players & Entities
- QIAGEN N.V. (company) — Registrant
- March 31, 2024 (date) — Quarterly period end date
- 001-38332 (other) — Commission File Number
- Venlo, The Netherlands (location) — Principal executive office location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public pursuant to the laws of its home country or jurisdiction, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What period does this specific 6-K filing cover?
This specific Form 6-K filing covers the quarterly period ended March 31, 2024.
Where is QIAGEN N.V.'s principal executive office located?
QIAGEN N.V.'s principal executive office is located at Hulsterweg 82, 5912 PL Venlo, The Netherlands.
What is the Commission File Number for QIAGEN N.V.?
The Commission File Number for QIAGEN N.V. is 001-38332.
Does QIAGEN N.V. file annual reports under Form 20-F or 40-F?
QIAGEN N.V. indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 744 words · 3 min read · ~2 pages · Grade level 12.5 · Accepted 2024-04-30 17:58:46
Filing Documents
- a2024q1prform6-k.htm (6-K) — 24KB
- exhibit9912024q1pr.htm (EX-99.1) — 354KB
- qiagen_logoa.jpg (GRAPHIC) — 68KB
- 0001015820-24-000031.txt ( ) — 473KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. QIAGEN N.V. By s Roland Sackers Roland Sackers Chief Financial Officer Date April 30, 2024 4 Table of Contents EXHIBIT INDEX Exhibit No. Exhibit 99.1 Press Release dated April 29, 2024 5